GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	ŠEDA Václav HOFERKOVÁ Eva ONDRIŠOVÁ Laura KOŠŤÁLOVÁ Lenka SHARMA Sonali LOJA Tomáš ZICHA Daniel VERNER Jan POSPÍŠILOVÁ Šárka BRYCHTOVÁ Yvona PANOVSKÁ Anna DOUBEK Michael MAYER Jiří MRÁZ Marek
Year of publication	2021
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Related projects:	Signaling propensity in the microenvironment of B cell chronic lymphocytic leukemia Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit VIII